BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/18/2024 3:42:21 AM | Browse: 118 | Download: 275
Publication Name World Journal of Diabetes
Manuscript ID 96953
Country China
Received
2024-05-19 14:41
Peer-Review Started
2024-05-19 14:41
To Make the First Decision
Return for Revision
2024-09-01 22:24
Revised
2024-09-22 00:46
Second Decision
2024-10-16 06:59
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-10-23 08:52
Articles in Press
2024-10-23 08:52
Publication Fee Transferred
2024-10-28 10:28
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-11-05 08:44
Publish the Manuscript Online
2024-11-18 03:30
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, General & Internal
Manuscript Type Case Report
Article Title Peroxisome proliferator-activated receptor gamma mutation in familial partial lipodystrophy type three: A case report and review of literature
Manuscript Source Unsolicited Manuscript
All Author List Chao-Jun Wu, Hao Liu, Li-Juan Tu and Jiong-Yu Hu
Funding Agency and Grant Number
Corresponding Author Jiong-Yu Hu, MD, Associate Professor, Department of Endocrinology, Rare Disease Center, The First Affiliated Hospital of Army Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China. jiongyu-hu@tmmu.edu.cn
Key Words Familial partial lipodystrophy; Peroxisome proliferator-activated receptor gamma; Tyr151Cys; Phenotypic heterogeneity; Case report
Core Tip This study reports a rare peroxisome proliferator-activated receptor gamma (PPARG) mutation (Y151C) in a 31-year-old woman with familial partial lipodystrophy type 3 (FPLD3), characterized by adipose tissue loss and metabolic complications. The mutation was identified in the PPARG DNA-binding domain. Pioglitazone, a PPARG agonist, effectively improved the patient’s glycemic and blood pressure control. This highlights the importance of genetic testing in FPLD3 diagnosis and the potential of PPARG agonists in managing metabolic complications.
Publish Date 2024-11-18 03:30
Citation <p>Wu CJ, Liu H, Tu LJ, Hu JY. Peroxisome proliferator-activated receptor gamma mutation in familial partial lipodystrophy type three: A case report and review of literature. <i>World J Diabetes</i> 2024; 15(12): 2360-2369</p>
URL https://www.wjgnet.com/1948-9358/full/v15/i12/2360.htm
DOI https://dx.doi.org/10.4239/wjd.v15.i12.2360
Full Article (PDF) WJD-15-2360-with-cover.pdf
CARE Checklist–2016 96953-CARE-Checklist-2016.pdf
Manuscript File 96953_Auto_Edited_020042.docx
Answering Reviewers 96953-answering-reviewers.pdf
Audio Core Tip 96953-audio.mp3
Conflict-of-Interest Disclosure Form 96953-conflict-of-interest-statement.pdf
Copyright License Agreement 96953-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s) 96953-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate 96953-non-native-speakers.pdf
Peer-review Report 96953-peer-reviews.pdf
Journal Editor-in-Chief Review Report 96953-journal-editor-in-chief.pdf
Scientific Misconduct Check 96953-scientific-misconduct-check.png
Scientific Editor Work List 96953-scientific-editor-work-list.pdf
CrossCheck Report 96953-crosscheck-report.png
CrossCheck Report 96953-crosscheck-report.pdf